A football manager says it is "empowering" to watch a team of people with Parkinson's disease playing the game. Nigel Osmond manages around 20 walking football players at Portishead Town FC who are ...
Oct. 5, 2025 — Stanford scientists found that aging disrupts the brain’s internal navigation system in mice, mirroring spatial memory decline in humans. Older mice struggled to recall familiar ...
July 3, 2025 — Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key brain cells, restoring vital dopamine communication and ...
An experimental therapy for Parkinson's disease being developed by Roche and Prothena has missed the mark in a phase 2b trial, leaving them sifting through the data for signals of efficacy. The PADOVA ...
AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by researchers at UCL and Newcastle University. The £26 million project ...
Parkinson's and Alzheimer's diseases are both caused by damage to brain cells and can happen at the same time. Alzheimer's disease always causes dementia, but Parkinson's disease can cause it too, ...
bCentre of Expertise for Parkinson and Movement Disorders, Department of Neurology, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback